In Vitro Butyrylcholinesterase Inhibitory Activity of Detarium Microcarpum, Epipremnum Aureum, and Prosopis Africana
BCHE Inhibitory Activity of Selected Plants
DOI:
https://doi.org/10.4314/t2b8cp44Keywords:
Detarium microcarpum, Alzheimer’s disease, butyrylcholinesterase inhibitory, Epipremium aureum, Prosopis africanaAbstract
Background: Alzheimer’s disease, a progressive neurodegenerative condition, is primarily associated with reduced cholinergic neurotransmission and notable memory loss. Cholinesterase inhibitors are considered valuable in the discovery of anti-Alzheimer’s agents. Recently, butyrylcholinesterase (BChE) inhibitors garnered significant attention in the development of anti-Alzheimer’s drugs due to their role in modulating cholinergic neurotransmission, and they are believed to hold promise in Alzheimer’s drug development, offering a complementary approach to traditional acetylcholinesterase (AChE) inhibitors.
Objective: The study investigates the anti-Alzheimer’s potential of Detarium microcarpum, Epipremnum aureum and Prosopis africana extracts.
Method: Extracts from the three medicinal plants were evaluated using an in vitro BChE inhibitoryassay, and the most active extract was fractioned to identify the activity-rich fraction.
Result: All extracts exhibited varying degrees of BChE inhibition. D. microcarpum demonstrated the most potent activity, with 87.26 ± 2.67% inhibition at 1 mg/mL and an IC50 of 0.10 ± 0.04 μg/ mL. In contrast, E. aureum and P. africana showed weaker inhibitory effects (16.15 ± 1.37% and 23.62 ± 1.91%, respectively) compared to D. microcarpum and were not pursued further. Among the fractions of D. microcarpum, the ethyl acetate and hexane fractions exhibited strong BChE inhibition (87.32 ± 2.06% and 72.18 ± 1.33%, respectively), with IC50 values of 0.10 ± 0.04 μg/mL and 0.27 ± 0.08 μg/mL, comparable to galantamine (90.37 ± 1.62%, IC50: 0.10 ± 0.07 μg/mL).
Conclusion: The stem bark of Detarium microcarpum demonstrates potent BChE inhibitory properties, suggesting its potential as an anti-Alzheimer agent.
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
